MRGPRX2 and mycosis fungoides: scRNAseq analysis of publicly available data from the skin of MF patients (13) and healthy skin (14) showed that 5.43-5.49% of MCs express MRGPRX2, whereas lymphocytes and keratinocytes showed minimal expression at 0.01% in the skin of MF patients (Figure 3).